Last updated: July 2026
Briavix provides commercial risk analytics — the Margin-at-Risk Diagnostic. It analyses documents you provide (invoices, purchase orders, contracts, shipment and receivables data) and produces a board-ready report quantifying commercial risk drivers and scenarios.
Briavix is not a bank, broker, insurer, credit provider, trading platform, hedge fund, or investment adviser. Briavix does not sell, arrange or underwrite insurance, financing or any regulated financial product, and does not hold or move client funds.
A Briavix report is commercial risk analytics, not financial, legal, tax or investment advice, and not a legal opinion. Any “next action” described in a report is phrased as a generic category — for example, discussing an FX forward line with a licensed bank, or reviewing trade credit insurance with a licensed broker — for you to pursue independently with a licensed or qualified provider of your choice. Briavix does not recommend a specific financial product or provider.
A diagnostic reflects the data provided and the scenarios modelled at a point in time. Briavix does not guarantee savings, protection, financing approval, insurance coverage, or any other financial outcome. Figures are analyst-validated where stated, but remain estimates based on the inputs available.
Report quality depends on the completeness and accuracy of the documents provided. Missing or incomplete data is flagged in the report rather than silently assumed — see the Methodology page for how confidence is scored.
Questions about this disclaimer can be sent to danil@briavix.com.